Cardiac tissue engineering represents a groundbreaking field at the intersection of medicine, biology, and engineering, aiming to address the challenges associated with heart diseases and organ transplantation. As a response to the limited availability of donor organs and the intricate nature of the heart, scientists are exploring innovative approaches to create functional cardiac tissues in the laboratory. This involves the use of biomaterials, stem cells, and advanced fabrication techniques to construct three-dimensional structures that mimic the intricate architecture of the heart. The ultimate goal is to develop viable tissue replacements that can integrate seamlessly with the patient's own heart, promoting regeneration and restoring proper cardiac function. This promising avenue holds the potential to revolutionize the treatment of heart diseases, offering personalized solutions and reducing the dependency on traditional transplantation methods. While challenges remain, including achieving electrical integration and vascularization, cardiac tissue engineering represents a beacon of hope in the quest for more effective treatments for cardiovascular disorders.
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain